1-3 of 3
Enkhtsetseg Purev
Close
Sort by
Journal Articles

Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study

Adam J. Olszewski, Tycel J. Phillips, Marc S. Hoffmann, Philippe Armand, Tae Min Kim, Dok Hyun Yoon, Amitkumar Mehta, Richard Greil, Jason Westin, Izidore S. Lossos, Javier L. Munoz, Jason Sit, Michael C. Wei, Annie Yang, Vivian Chen, Enkhtsetseg Purev, Donald L. Yee, Ulrich Jaeger
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6055–6065.
https://doi.org/10.1182/bloodadvances.2023010840
Published: 2023
Includes: Supplemental data
Journal Articles

Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant

Clinical Trials & Observations
Prashant Sharma, Enkhtsetseg Purev, Bradley Haverkos, Daniel A. Pollyea, Evan Cherry, Manali Kamdar, Tomer Mark, Peter Forsberg, Daniel Sherbenou, Andrew Hammes, Rachel Rabinovitch, Clayton A. Smith, Jonathan A. Gutman
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2227–2235.
https://doi.org/10.1182/bloodadvances.2020001554
Published: 2020
Journal Articles

Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia

Clinical Trials & Observations
Amanda C. Winters, Jonathan A. Gutman, Enkhtsetseg Purev, Molly Nakic, Jennifer Tobin, Stephanie Chase, Jeff Kaiser, Lindsey Lyle, Chelsey Boggs, Keri Halsema, Jeffrey T. Schowinsky, Julie Rosser, Mark D. Ewalt, Bradford Siegele, Vishal Rana, Steven Schuster, Diana Abbott, Brett M. Stevens, Craig T. Jordan, Clayton Smith, Daniel A. Pollyea
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2911–2919.
https://doi.org/10.1182/bloodadvances.2019000243
Published: 2019
Includes: Supplemental data